Company / PP&E (Net)
SOLENO THERAPEUTICS INC PP&E (Net) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$185.0K
FY2025
5-year range
$12.0K / $186.0K
FY2021-FY2025
Trend
-0.5%
vs FY2024
Sector context
#181 of 195
Health Care
What the data says
Among 195 Health Care companies, SOLENO THERAPEUTICS INC is in the bottom 7% for pp&e (net). PP&E (Net) has fluctuated over the past 10 years, ranging from $12,000 in FY2023 to $186,000 in FY2024.
Based on SEC 10-K filings.
$185,000 in FY2025 with a 5-year CAGR of +57.6%.
Improved from $12,000 to $185,000 over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +92.3%
- 5-Year CAGR
- +57.6%
- 10-Year CAGR
- -
Sector benchmark
Bottom 7% in Health CareTop 93% of 195This company $185.0K Sector average $770.1M
▼
-100.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +57.6%, indicating consistent growth.
- In FY2025, pp&e (net) decreased 0.5% year-over-year.
- Ranks #181 out of 195 companies in the Health Care sector.
- Peak pp&e (net) was recorded in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $185.0K | -0.5% |
| FY2024 | $186.0K | +1450.0% |
| FY2023 | $12.0K | -53.8% |
| FY2022 | $26.0K | -21.2% |
| FY2021 | $33.0K | +73.7% |
| FY2020 | $19.0K | -13.6% |
| FY2019 | $22.0K | +83.3% |
| FY2018 | $12.0K | -47.8% |
| FY2017 | $23.0K | -45.3% |
| FY2016 | $42.0K | -51.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026